OKYO News and Press, OKYO Pharma Limited From 03/01/23

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Koshiro K / Shutterstock Xpeng (NYSE: XPEV ) stock is worth checking on Wednesday after the EV company released delivery data for February. During February 2023, Xpeng delivered a total of 6,010 Smart EVs...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: benjamin poturak / Shutterstock.com Novavax (NASDAQ: NVAX ) stock is dropping on Wednesday after the vaccine company warned investors about the state of its business. In its latest earnings report, Novavax...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock OKYO Pharma (NASDAQ: OKYO ) stock is taking a beating on Wednesday despite recent progress toward a clinical trial . The latest news from OKYO Pharma is that its GMP-packaged OK-101 drug for ...

London-based Okyo Pharma ( NASDAQ: OKYO ) it received customs clearance in the U.S. for its GMP packaged OK-101 drug, shipped from Europe, to be used in an upcoming phase 2 trial in patients with dry eye disease (DED). Okyo expects the first-patient-first visit in Q1 2023 an...

LONDON and NEW YORK, Feb. 28, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye disease (DED) to address the significant unmet need in this multi-billion-dollar market, today anno...

(NewsDirect) By David Willey, Benzinga An eye condition that has been described as a common disease currently affects as many as 49 million Americans . Dry Eye Disease (DED) afflicts over 15% of Americans over 50 and disproportionately affects women and DED patients are not well s...

--News Direct-- By David Willey, Benzinga An eye condition that has been described as a common disease currently affects as many as 49 million Americans . Dry Eye Disease (DED) afflicts over 15% of Americans over 50 and disproportionately affects women and DED patients are not wel...

LONDON and NEW YORK, Feb. 23, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO, NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company developing OK-101 to treat dry eye disease (DED) to address the significant unmet need in this multi-billion-dollar market, today announces the...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Alex Kravtsov / Shutterstock.com Alibaba (NYSE: BABA ) stock is a hot topic on Tuesday as investors react to news of Ant Group teaming up with China’s NBA league . With this news, Ant Group, a fi...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock OKYO Pharma  (NASDAQ: OKYO ) stock is falling on Tuesday as the company prepares for a presentation this week . OKYO Pharma is attending the 2nd Annual GPCRs-Targeted Drug Discovery Summi...